Increased ribavirin biodisponibility associated with telaprevir use in HCV patients treated with PEG-IFN/ribavirin/telaprevir triple therapyFrancois Bailly,Pierre Pradat,Marianne Maynard-Muet,Mathilde Leclercq,Victor Virlogeux,Patrick Miailhes,Giorgiana Hatu,Majid Amiri,Fanny Lebosse,Fabien Zoulim,Marie-Claude GagnieuHEPATOLOGY(2013)引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要